Satsuma Pharmaceuticals Net Tangible Assets

Satsuma Pharmaceuticals (STSA) currently reports a net tangible assets of $38M as of March 2023. That compares with $87M in the prior-year period — down 56.7% year over year. Use the charts on this page to explore Satsuma Pharmaceuticals's net tangible assets history and peer comparisons.

Satsuma Pharmaceuticals's net tangible assets decreased from $87M to $38M — a 56.7% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Satsuma Pharmaceuticals reported $38M in net tangible assets as of March 2023. That compares with $87M in the prior-year period — down 56.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $38M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Satsuma Pharmaceuticals, and consider following STSA for alerts when major investors trade the stock.

Satsuma Pharmaceuticals is classified in the Healthcare sector. On net tangible assets, it currently shows $38M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing STSA with unrelated industries.